ENOV(Enovis Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $1.43B | $1.56B | $1.71B | $2.11B | $2.25B |
| 毛利润 | $777.67M | $869.38M | $990.78M | $1.18B | $1.35B |
| 营业利润 | −$62.80M | −$71.18M | −$65.71M | −$775.72M | −$1.12B |
| 净利润 | $71.66M | −$13.29M | −$33.26M | −$825.49M | −$1.18B |
| 经营现金流 | $356.10M | −$55.86M | $134.99M | $113.50M | $217.29M |
| 自由现金流 | $251.86M | −$161.31M | $12.77M | −$67.21M | $19.92M |
| 摊薄每股收益 | — | $-0.25 | $-0.61 | $-14.93 | $-20.75 |